Gwo Xi Stem Cell Applied Technology Co. , Ltd (TPEX:6704)
23.75
+0.05 (0.21%)
Feb 11, 2026, 1:55 PM CST
TPEX:6704 Revenue
Gwo Xi Stem Cell Applied Technology Co. , had revenue of 94.49M TWD in the half year ending June 30, 2025, with 34.44% growth. This brings the company's revenue in the last twelve months to 184.91M, up 22.87% year-over-year. In the year 2024, Gwo Xi Stem Cell Applied Technology Co. , had annual revenue of 170.03M with 20.44% growth.
Revenue (ttm)
184.91M
Revenue Growth
+22.87%
P/S Ratio
12.32
Revenue / Employee
n/a
Employees
34
Market Cap
2.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 170.03M | 28.85M | 20.44% |
| Dec 31, 2023 | 141.18M | -39.49M | -21.86% |
| Dec 31, 2022 | 180.67M | -62.09M | -25.58% |
| Dec 31, 2021 | 242.75M | 54.21M | 28.75% |
| Dec 31, 2020 | 188.54M | 11.86M | 6.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Synbio Tech | 1.00B |
| Chunghwa Chemical Synthesis & Biotech | 977.79M |
| G&E Herbal Biotechnology | 311.78M |
| HeXun Biosciences | 290.83M |
| Sunny Pharmtech | 290.18M |
| GlycoNex Incorporation | 36.63M |
| TaiRx | 15.46M |
| Anti-Microbial Savior BioteQ | 612.00K |